• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Confirma expands R&D, names exec

Article

MR software developer Confirma has entered into a research agreement with the Robert M. Berk Magnetic Resonance Institute at the University of California, San Diego, to conduct MR research using the company's breast MR image processing and analysis

MR software developer Confirma has entered into a research agreement with the Robert M. Berk Magnetic Resonance Institute at the University of California, San Diego, to conduct MR research using the company's breast MR image processing and analysis package. The purpose of this agreement is to further evaluate the product, called CADstream, and assess its impact on breast MRI interpretation. The first study will focus on measuring the effect of CADstream processing on reader sensitivity and specificity.

The evolution of this product will be conducted under new corporate leadership. The company announced March 27 that Max Lyon had been appointed president and CEO. Lyon was most recently the president and CEO of LifeSpex, a development-stage company applying light-based technologies to early cancer detection. From 1998 to 2000, he was a founder, director, and CEO of NexCura (formerly Cancerfacts.com), a Web-based cancer management company. From 1988 to 1998, Lyon served as CEO and a director of Bard Diagnostics (formerly Bainbridge Sciences), a wholly owned subsidiary of C.R. Bard.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.